Drug Firm That Hiked Prices By 6,000% Paid Shareholders £400 Million
A pharmaceuticals firm that inflated thyroid drug prices by up to 6,000% over a decade paid out more than £400m to shareholders and directors during the same period.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
Drug Firm That Hiked Prices By 6,000% Paid Shareholders £400 Million
A pharmaceuticals firm that inflated thyroid drug prices by up to 6,000% over a decade paid out more than £400m to shareholders and directors during the same period.